Importantly, in mice, IL-17-producing γδ T cells (Vγ4+ and Vγ6+) contribute to chemotherapy efficacy because they are required for the priming of IFN-γ-secreting tumor-specific T cells. This evidence concerns the gene IFNG and neoplasm.